Sunday 18 October 2026
Export AFIB’s income statement to Excel — free account
Acutus Medical, Inc.
AFIB Healthcare Medical Devices
In the quarter to December 2024, revenue grew 204.2%, EPS grew 95.9% and free cash flow grew 76.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.
0.00
0.00
NaN
Follow AFIB
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Trend | 2025e | 2026e | 2027e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | 22.26 | 2.98 | 0.48 | 0.16 | 0.03 |
Analyst estimates 2025–2027 Powerpack |
|||
| High | — | — | — | — | — | 38.99 | 34.35 | 4.00 | 1.96 | 0.43 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | 224 | 291 | 338 | 225 | 233 | 85 | ||||
| Revenue/emp, $m | — | — | — | 0.00 | 0.01 | 0.03 | 0.05 | 0.01 | 0.03 | 0.24 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | 2 | 3 | 8 | 17 | 3 | 7 | 20 | ||||
| Gross margin, % | — | — | — | (246.72) | (225.92) | (87.72) | (90.73) | (63.02) | (43.79) | 5.03 | |||||
| EBT | — | — | — | (48) | (97) | (102) | (118) | 29 | (12) | (5) | |||||
| EBT margin, % | — | — | — | (2,211.77) | (3,421.69) | (1,204.61) | (681.71) | 951.77 | (165.52) | (22.50) | |||||
| Net income | — | — | 0 | (48) | (97) | (102) | (118) | (40) | (82) | (10) | |||||
| Depreciation | — | — | — | 5 | 21 | 5 | 10 | 14 | 0 | 2 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | 3.97 | 4.22 | 0.74 | 0.60 | 0.11 | 0.25 | 0.68 | ||||
| Earnings | — | — | — | (87.78) | (144.40) | (8.94) | (4.11) | (1.40) | (2.81) | (0.32) | |||||
| Cash flow | — | — | — | (61.89) | (83.31) | (7.47) | (3.48) | (3.12) | (2.17) | (1.06) | |||||
| Capex | — | — | — | (3.73) | (19.93) | (0.98) | (0.35) | (0.01) | (0.01) | 0.00 | |||||
| Free cash flow | — | — | — | (65.62) | (103.25) | (8.45) | (3.83) | (3.13) | (2.18) | (1.07) | |||||
| Book value | — | — | — | (24.74) | 40.99 | 11.10 | 3.69 | 2.63 | (0.03) | (0.39) | |||||
| Shares, m | — | — | — | 1 | 1 | 11 | 29 | 28 | 29 | 30 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| P/S | — | — | — | 4.73 | 4.73 | 38.83 | 5.66 | 13.06 | 0.85 | 0.09 | |||||
| P/B | — | — | — | 0.00 | 0.00 | 2.60 | 0.92 | 0.53 | 0.00 | 0.00 | |||||
| EV/Sales | — | — | — | 7.20 | 7.20 | 28.05 | 2.18 | (0.62) | 1.56 | 1.01 | |||||
| EV/FCF | — | — | — | (0.38) | (0.38) | (2.46) | (0.34) | 0.02 | (0.18) | (0.64) | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | (34) | (56) | (85) | (100) | (89) | (63) | (32) | ||||
| Capex | — | — | — | (2) | (13) | (11) | (10) | 0 | 0 | 0 | |||||
| Free cash flow | — | — | — | (36) | (69) | (96) | (110) | (89) | (63) | (32) | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | (3) | 51 | 129 | 108 | 98 | 27 | 13 | ||||
| Total debt | — | — | — | 26 | 39 | 40 | 41 | 35 | 35 | 33 | |||||
| Net debt | — | — | — | 8 | (33) | (91) | (60) | (41) | 5 | 19 | |||||
| Shareholders’ equity | — | — | — | (14) | 28 | 127 | 106 | 75 | (1) | (12) | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | (369.25) | (147.70) | (68.45) | (64.96) | (26.13) | (87.15) | (23.11) | ||||
| ROIC | — | — | — | 0.00 | 0.00 | (161.69) | (153.63) | 76.43 | (174.27) | (0.51) | |||||
| ROE | — | — | — | 26.79 | 54.27 | 205.55 | (101.32) | (43.84) | (220.29) | 153.11 | |||||
Negative figures in brackets.
Fiscal years to Dec 2024 · latest quarter Dec 2024
Charts ten years each
Acutus Medical, Inc. vs peers in Medical Devices (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| NXL Nexalin Technology, Inc. | $2.6M | — (loss-making) | — (loss-making) | −82.72% (below 0%: shrinking) | n/m | −97.23% (below 0%: shrinking) | 72.95% | (18,420.49%) | Compare |
| BIOLQ Biolase, Inc. | $2.3M | — (loss-making) | — (loss-making) | −0.65% (below 0%: shrinking) | n/m | −60.22% (below 0%: shrinking) | 40.39% | (6.41%) | Compare |
| XAIR Beyond Air, Inc. | $2.2M | — (loss-making) | — (loss-making) | +0.45% (above 0%: growing) | n/m | −9.10% (below 0%: shrinking) | 12.73% | (373.98%) | Compare |
| NUVOQ Holdco Nuvo Group D.G Ltd. | $2.1M | — (loss-making) | — | — | n/m | −1.05% (below 0%: shrinking) | 0.00% | 0.00% | Compare |
| VJET Flyte Aviation, Inc. | $2.1M | — (loss-making) | — (loss-making) | +380.66% (above 0%: growing) | n/m | −26.70% (below 0%: shrinking) | 9.62% | (388.13%) | Compare |
| NUWE Nuwellis, Inc. | $2.0M | — (loss-making) | — (loss-making) | +14.14% (above 0%: growing) | n/m | −51.55% (below 0%: shrinking) | 76.08% | (160.94%) | Compare |
| AFIB Acutus Medical, Inc. | $1.7M | — (loss-making) | — (loss-making) | +204.18% (above 0%: growing) | n/m | +76.40% (above 0%: growing) | 14.20% | (3.81%) | |
| DHAI DIH Holding US, Inc. | $1.6M | — (loss-making) | — | −30.67% (below 0%: shrinking) | n/m | −167.90% (below 0%: shrinking) | 50.33% | (33.62%) | Compare |
| DYNTQ Dynatronics Corporation | $1.2M | — (loss-making) | — (loss-making) | −7.61% (below 0%: shrinking) | n/m | −193.04% (below 0%: shrinking) | 24.65% | (1.26%) | Compare |
| Median of peers | $2.1M | — | — | −0.65% | — | −55.88% | 32.52% | (97.28%) |
Acutus Medical, Inc. (AFIB) key facts
- Acutus Medical, Inc. (AFIB) is a Medical Devices company in the Healthcare sector.
- Return on equity was 153.1% and debt-to-equity -2.81.
- Its Piotroski F-score is 3 out of 9 and its Altman Z-score is −28.52 (distress zone) for fiscal 2024.